The Partners • RespirageneTM - For the first time, with the RespirageneTM test, you can learn your individual level of risk of developing lung cancer, compared to other smokers.x

The Mission The Expertise The Research The Partners

My Account

GENETIC TESTING SMOKING AND GENES RESPIRAGENE™ SNPs RESPIRAGENE™ SCORE

SMOKER EX-SMOKER TRYING TO QUIT FRIENDS & FAMILY

YOUR PERSONALIZED SCORE ACTIONABLE RESULTS TRUSTWORTHY RESULTS CLIA-CERTIFIED LABORATORY GENETIC COUNSELING PRIVACY & SECURITY

Strategic Partnerships

Respiragene™ benefits from a global network of researchers and advocacy groups highly motivated to maximize the medical and social benefits of genetic risk assessment in smoking related disease.

The University of Auckland (New Zealand)

New Zealand's largest university provides ongoing research support services to Synergenz through close cooperation with Auckland UniServices Limited, the School of Biological Sciences and the School of Medicine.

View website

Synergenz BioScience LTD (Hong Kong)

Synergenz BioScience Ltd was formed in 2004 to commercialize discoveries about lung disease susceptibility first made by Dr. Robert P Young in research conducted at the University of Auckland in New Zealand. The Company licenses its core intellectual property and related marketing services in key markets around the world. The Company was originally spun off from Auckland University and backed by the Hong Kong-based Pacific Group Ltd. and its investment partners. Synergenz's research program continues in New Zealand and in collaboration with leading investigators, licensees and commercial partners around the world. Synergenz BioScience, Inc., located in Evanston, Illinois has been established to provide marketing services.

View website

INFORMATION

ABOUT RESPIRAGENE™

POLICIES

The content of this website is not intended to be a substitute for advice, diagnosis, or treatment by a physician,or to constitute professional medical advice.